Chemfab Alkalis Ltd
Incorproated in 2009, Chemfab
Alkalis Ltd manufactures basic
inorganic chemicals and PVCO
pipes[1]
- Market Cap ₹ 477 Cr.
- Current Price ₹ 332
- High / Low ₹ 530 / 270
- Stock P/E
- Book Value ₹ 263
- Dividend Yield 0.38 %
- ROCE 1.03 %
- ROE -2.49 %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 11.5% over past five years.
- Company has a low return on equity of 1.02% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Part of BSE Commodities
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30 | 25 | 140 | 180 | 193 | 205 | 181 | 272 | 331 | 327 | 334 | 311 | 292 | |
| Sales growth | +45% | -17% | +465% | +28% | +8% | -12% | +50% | +22% | -1% | +2% | -7% | -15% | |
| 29 | 18 | 108 | 128 | 133 | 149 | 157 | 215 | 221 | 273 | 290 | 284 | 264 | |
| Operating Profit | 0 | 7 | 32 | 52 | 61 | 55 | 24 | 57 | 111 | 55 | 44 | 27 | 28 |
| OPM % | 1.3% | 27% | 23% | 29% | 31% | 27% | 13% | 21% | 33% | 17% | 13% | 9% | 9% |
| 3 | 0 | 2 | 4 | -15 | -0 | 1 | 6 | 2 | 9 | -3 | 9 | 8 | |
| Interest | 7 | 3 | 5 | 4 | 2 | 4 | 3 | 1 | 1 | 2 | 6 | 8 | 9 |
| Depreciation | 4 | 4 | 13 | 12 | 15 | 25 | 20 | 22 | 23 | 22 | 36 | 28 | 31 |
| Profit before tax | -7 | 0 | 16 | 40 | 28 | 27 | 2 | 39 | 89 | 39 | -0 | -0 | -4 |
| Tax % | 0% | 0% | 6% | 36% | 41% | 5% | 500% | 26% | 28% | 33% | 2,210% | 1,615% | |
| -7 | 0 | 16 | 25 | 17 | 25 | -8 | 29 | 65 | 26 | -7 | -3 | -0 | |
| EPS in Rs | 18.42 | 12.07 | 18.26 | -5.78 | 20.34 | 45.54 | 18.50 | -4.83 | -2.39 | -0.25 | |||
| Dividend Payout % | 0% | 0% | 11% | 7% | 10% | 7% | 0% | 6% | 3% | 7% | -26% | -52% |
(S): Standalone figures, shown where consolidated figures are not available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 11% |
| 3 Years: | -2% |
| TTM: | -15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -3% |
| 3 Years: | % |
| TTM: | -127% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 15% |
| 3 Years: | -4% |
| 1 Year: | -35% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 6% |
| 3 Years: | 1% |
| Last Year: | -2% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 7 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
| Reserves | -24 | -17 | 201 | 222 | 237 | 262 | 253 | 284 | 347 | 373 | 366 | 361 | 363 |
| 82 | 66 | 16 | 23 | 34 | 43 | 32 | 9 | 2 | 20 | 84 | 126 | 144 | |
| 10 | 14 | 44 | 39 | 36 | 30 | 36 | 46 | 48 | 93 | 57 | 76 | 61 | |
| Total Liabilities | 73 | 70 | 275 | 298 | 321 | 348 | 335 | 352 | 412 | 500 | 522 | 577 | 582 |
| 61 | 57 | 164 | 173 | 194 | 195 | 202 | 194 | 192 | 247 | 317 | 387 | 380 | |
| CWIP | 0 | 1 | 11 | 2 | 10 | 35 | 3 | 8 | 31 | 74 | 36 | 31 | 33 |
| Investments | 0 | 0 | 0 | 0 | 0 | 1 | 24 | 31 | 68 | 5 | 16 | 14 | 15 |
| 12 | 12 | 99 | 124 | 117 | 118 | 105 | 119 | 121 | 174 | 152 | 146 | 155 | |
| Total Assets | 73 | 70 | 275 | 298 | 321 | 348 | 335 | 352 | 412 | 500 | 522 | 577 | 582 |
(S): Standalone figures, shown where consolidated figures are not available.
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1 | 38 | 44 | 41 | 54 | 45 | 55 | 93 | 31 | 40 | 38 | ||
| -1 | -9 | -30 | -47 | -58 | -6 | -21 | -48 | -110 | -86 | -81 | ||
| 0 | -30 | -13 | 6 | 3 | -16 | -25 | -9 | 16 | 59 | 31 | ||
| Net Cash Flow | -2 | -1 | 1 | 0 | -1 | 23 | 9 | 36 | -62 | 13 | -12 | |
| Free Cash Flow | -2 | 30 | 19 | -11 | -4 | 38 | 35 | 40 | -60 | -71 | -38 | |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | -11% | 113% | 101% | 85% | 110% | 157% | 107% | 97% | 74% | 104% | 142% |
(S): Standalone figures, shown where consolidated figures are not available.
Ratios
Consolidated / View Standalone
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 42 | 9 | 22 | 35 | 31 | 17 | 31 | 29 | 24 | 24 | 23 | 28 |
| Inventory Days | 320 | 203 | 152 | 84 | 79 | 54 | 89 | 60 | 100 | 92 | ||
| Days Payable | 64 | 546 | 225 | 165 | 154 | 92 | 145 | 101 | 118 | 111 | ||
| Cash Conversion Cycle | 298 | -334 | 22 | 35 | -43 | -63 | -45 | -9 | -32 | -18 | 4 | 9 |
| Working Capital Days | -208 | -329 | -25 | -31 | 10 | -2 | 15 | 5 | 7 | -24 | 28 | -1 |
| ROCE % | -0% | 6% | 15% | 17% | 18% | 2% | 13% | 28% | 10% | 3% | 1% |
(S): Standalone figures, shown where consolidated figures are not available.
Insights
In beta| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Caustic Soda Installed Capacity TPA |
|
|||||||||
| OPVC Pipes Installed Capacity TPA ・Standalone data |
||||||||||
| Caustic Soda Capacity Utilisation % |
||||||||||
| ECU Realisation (Chlor-Alkali) INR/MT ・Standalone data |
||||||||||
| OPVC Pipes Capacity Utilisation % |
||||||||||
| OPVC Pipes Sales Volume kt |
||||||||||
| States Approved for OPVC Pipes count ・Standalone data |
||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Submission of Newspaper Clippings of Un-Audited Financial Results for the quarter and half year ended 30th September 2026, approved vide board meeting held on 28th …
-
Announcement under Regulation 30 (LODR)-Investor Presentation
- Submission of Investor presentation for quarter ended September 30, 2026.
-
Submission Of Intimation Wrt Board Approval Of The Changes In Designations In Composition Of The Stakeholders Relationship Committee
- Board approved Q2 FY27 results and appointed V. R. Raguraman as COO effective 28 October 2026.
-
Announcement under Regulation 30 (LODR)-Change in Management
- Board approved Q2 FY27 standalone and consolidated results; appointed V.R. Raguraman as COO effective 28 October 2026.
-
Unaudited Financial Results Along With Limited Review Report From Statutory Auditors For Quarter And Half Year Ended 30Th September 2026
- Board approved Q2/H1 FY2026-27 results and appointed V.R. Raguraman as COO.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Business Overview:[1][2]
CAL is an ISO 14001 and OHSAS 18001 certified manufacturer of choloro alkali products. It uses Membrane Technology for Chloralkali production. Company also produces chlorine, hydrogen, sodium hypo chlorite, and hydrochloric acid as by-products from manufacture of caustic soda